How I Approach Treatment of Relapsed Acute Lymphoblastic Leukemia in Patients With Down Syndrome
{{output}}
Children with Down syndrome (DS) experience excessive treatment-related mortality (TRM), primarily due to infectious complications, during treatment for acute lymphoblastic leukemia (ALL). This risk further increases during the intensive chemotherapy required ... ...
